Schedule 13G ownership disclosure
CYTOMED THERAPEUTICS LIMITED
Ordinary Shares, no par value per share · CUSIP: Y1R80M106
Event date: 2026-10-12
- Filing-level shares
- 1,191,523
- Percent of class
- 9.984%
- mDR LTD
Shares: 1,191,523 · Class: 9.984%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001477932-26-006422
- Form type
- SCHEDULE 13G/A
- Filer
- mDR Ltd
- CIK
- CIK 1973616
- Filed
- Oct 23, 2026
- Reporting period
- Oct 12, 2026
- Description
- Schedule 13G beneficial ownership